These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 18566559)

  • 1. Transjugular Intrahepatic Porto-Caval Shunt (TIPS) in treatment of portal hypertension in liver transplant recipiens.
    Wróblewski T; Rowiński O; Zurakowski J; Ziarkiewicz-Wróblewska B; Zieniewicz K; Nyckowski P; Krawczyk M
    Ann Transplant; 2008; 13(2):42-5. PubMed ID: 18566559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
    Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U
    Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transjugular intrahepatic portosystemic shunt: Indications, complications, survival and its use as a bridging therapy to liver transplant in Western Australia.
    Pateria P; Jeffrey GP; Garas G; Tibballs J; Ferguson J; Delriviere L; Huang Y; Adams LA; MacQuillan G
    J Med Imaging Radiat Oncol; 2017 Aug; 61(4):441-447. PubMed ID: 28070962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Intrahepatic portocaval shunt as a new method for treating and prevention of bleeding from esophageal varices in portal hypertension].
    Wróblewski T; Rowiński O; Pawlak J; Polański S; Jaworski M; Michałowicz B; Małkowski P; Karwowski A; Pruszyński B
    Przegl Lek; 1998; 55(9):469-74. PubMed ID: 10085726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of transjugular intrahepatic portosystemic shunts in liver-transplant recipients.
    Choi DX; Jain AB; Orloff MS
    J Am Coll Surg; 2009 Apr; 208(4):539-46. PubMed ID: 19476787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transjugular intrahepatic portosystemic shunt: efficacy for the treatment of portal hypertension and impact on liver transplantation.
    Cosenza CA; Hoffman AL; Friedman ML; Sher LS; Lopez RR; Van Allen R; Brown DH; Fraiman MH; Arnaout W; Vierling J; Makowka L
    Am Surg; 1996 Oct; 62(10):835-9. PubMed ID: 8813166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Covered stents are better than uncovered stents for transjugular intrahepatic portosystemic shunts in cirrhotic patients with refractory ascites: a retrospective cohort study.
    Maleux G; Perez-Gutierrez NA; Evrard S; Mroue A; Le Moine O; Laleman W; Nevens F
    Acta Gastroenterol Belg; 2010; 73(3):336-41. PubMed ID: 21086935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transjugular intrahepatic portosystemic shunt migration in patients undergoing liver transplantation.
    Khan TT; Reddy KS; Johnston TD; Lo FK; Shedlofsky S; Grubb S; Ranjan D
    Int Surg; 2002; 87(4):279-81. PubMed ID: 12575815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction in portal venous pressure by transjugular intrahepatic portosystemic shunt for treatment of hemorrhagic stomal varices.
    Deipolyi AR; Kalva SP; Oklu R; Walker TG; Wicky S; Ganguli S
    AJR Am J Roentgenol; 2014 Sep; 203(3):668-73. PubMed ID: 25148174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CXCL9 is a prognostic marker in patients with liver cirrhosis receiving transjugular intrahepatic portosystemic shunt.
    Berres ML; Asmacher S; Lehmann J; Jansen C; Görtzen J; Klein S; Meyer C; Strunk HM; Fimmers R; Tacke F; Strassburg CP; Trautwein C; Sauerbruch T; Wasmuth HE; Trebicka J
    J Hepatol; 2015 Feb; 62(2):332-9. PubMed ID: 25457205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A comparison of efficacies between transjugular intrahepatic portosystemic shunt versus portoazygos devascularization in the treatment of portal hypertension with variceal bleeding].
    Xu XB; Chu JG; Huang H; Zhang HY; Zhang HY; Liu CL; Xiao M; Zhang H; Feng ZQ; Zhao G
    Zhonghua Yi Xue Za Zhi; 2012 Sep; 92(36):2542-5. PubMed ID: 23158794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of a transjugular intrahepatic portosystemic shunt combined with autologous bone marrow cell infusion in patients with decompensated liver cirrhosis: an exploratory study.
    Huang M; Feng Z; Ji D; Cao Y; Shi X; Chen P; Wang P; Tang M; Liu K
    Cytotherapy; 2014 Nov; 16(11):1575-1583. PubMed ID: 25287603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of ultrasound surveillance of transjugular intrahepatic portosystemic shunts in the covered stent era.
    Carr CE; Tuite CM; Soulen MC; Shlansky-Goldberg RD; Clark TW; Mondschein JI; Kwak A; Patel AA; Coleman BG; Trerotola SO
    J Vasc Interv Radiol; 2006 Aug; 17(8):1297-305. PubMed ID: 16923976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two-stage transjugular intrahepatic porta-systemic shunt for patients with cirrhosis and a high risk of portal-systemic encephalopathy patients as a bridge to orthotopic liver transplantation: a preliminary report.
    Wróblewski T; Rowiński O; Ziarkiewicz-Wróblewska B; Górnicka B; Albrecht J; Jones EA; Krawczyk M
    Transplant Proc; 2006; 38(1):204-8. PubMed ID: 16504703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver perfusion scintigraphy prior to and after transjugular intrahepatic portosystemic shunts (TIPS) in patients with portal hypertension.
    Willkomm P; Schomburg A; Brensing KA; Reichmann K; Bangard M; Overbeck B; Sauerbruch T; Biersack HJ
    Nuklearmedizin; 2000 Aug; 39(5):139-41. PubMed ID: 10984890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of Budd-Chiari syndrome in a liver transplant unit, the role of transjugular intrahepatic porto-systemic shunt and liver transplantation.
    Attwell A; Ludkowski M; Nash R; Kugelmas M
    Aliment Pharmacol Ther; 2004 Oct; 20(8):867-73. PubMed ID: 15479358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Transjugular intrahepatic portosystemic shunting with covered stents in children: a preliminary study of safety and patency].
    Zurera LJ; Espejo JJ; Canis M; Bueno A; Vicente J; Gilbert JJ
    Radiologia; 2014; 56(4):339-45. PubMed ID: 22704684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes after transjugular intrahepatic portosystemic stent shunt: a "bridge" to nowhere.
    Toomey PG; Ross SB; Golkar FC; Hernandez JM; Clark WC; Luberice K; Alsina AE; Rosemurgy AS
    Am J Surg; 2013 Apr; 205(4):441-6. PubMed ID: 23375760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prosthetic H-graft portacaval shunts vs transjugular intrahepatic portasystemic stent shunts: 18-year follow-up of a randomized trial.
    Rosemurgy AS; Frohman HA; Teta AF; Luberice K; Ross SB
    J Am Coll Surg; 2012 Apr; 214(4):445-53; discussion 453-5. PubMed ID: 22463885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transjugular intrahepatic portosystemic shunt following liver transplantation: can outcomes be predicted?
    El Atrache M; Abouljoud M; Sharma S; Abbass AA; Yoshida A; Kim D; Kazimi M; Moonka D; Brown K
    Clin Transplant; 2012; 26(4):657-61. PubMed ID: 22309034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.